Physicians' Academy for Cardiovascular Education

PCSK9: The promise of a new target in lipid management

Prof. John E Deanfield, UCL, London

Sep. 3, 2014 - Barcelona, ESC - Prof. John E Deanfield, UCL, London

Prof. John E Deanfield, London introducing the rationale for PCSK9 inhibition with a lecture held during the EBAC accredited symposium on innovations in lipid management at ESC 2014 in Barcelona

Educational information

The educational programme at ESC was CME accredited by EBAC.

This online session is not accredited, but similar in content

Start video